Breast cancer (metastatic)
Would you like to receive a message when there is new research on Breast Cancer (metastatic)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication appears one sentence explaining what was investigated — and you'll be notified as soon as there is new research on Breast cancer (metastatic). View what Premium costs.
Publications and studies (2757)
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Efficacy of doxorubicin-loaded graphene nanoplatform chemo-photothermal therapy versus photothermal therapy alone for breast cancer xenograft tumors: a meta-analysis. (2026/12/01) ♡
- Relationship between bisphosphonate use and risks of recurrence and mortality among hormone receptor-positive and triple-negative breast cancer patients. (2026/08/15) ♡
- The role of fatigue and sleep quality in the link between pain severity, perceived injustice and pain catastrophizing in breast cancer survivors with pain: a network analysis. (2026/08/11) ♡
- Ethnic Differences in Psychosocial Factors for Cancer Survivorship Among Asian American Breast Cancer Survivors: Secondary Outcomes of a Randomized Controlled Trial. (2026/08/11) ♡
- Clinical assessment and management of bone health in non-metastatic breast cancer patients: a best practice implementation project. (2026/08/11) ♡
- High-throughput deformability-based microfluidic sorting reveals metastatic cancer subpopulations. (2026/08/11) ♡
- Response to neoadjuvant chemotherapy as a potential indicator of internal mammary node involvement in early breast cancer. (2026/08/10) ♡
- Cognitive workload and its relationship with neurocognitive performance before and after breast cancer chemotherapy. (2026/08/10) ♡
- Prevalence and outcome of metastases to the thyroid gland: a nationwide database study. (2026/08/10) ♡
- Interstitial lung disease in metastatic breast cancer: a landscape review using SEER-Medicare. (2026/08/10) ♡
- DHRS2 regulates epithelial-mesenchymal transition in breast cancer cells. (2026/08/10) ♡
- Sex differences in chemotherapy-induced alopecia distress using the Japanese version of the Chemotherapy-Induced Alopecia Distress Scale. (2026/08/10) ♡
- Liquid Biopsies for Cancer: A Translational Science Review. (2026/08/10) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Randomized phase 2 trial of a PARP inhibitor TSL-1502 in germline BRCA-mutated, HER2-negative locally advanced/metastatic breast cancer. (2026/08/10) ♡
- Time-restricted eating to entrain circadian rhythms, increase physiological responsiveness, and prevent stressor-induced frailty: A pilot randomized controlled trial. (2026/08/08) ♡
- Long-term results of preoperative hypofractionated chemoradiotherapy for high-risk HER2-positive and triple-negative breast cancer subtypes. (2026/08/08) ♡
- Phase 2 test of QBS72S for breast cancer leptomeningeal disease. (2026/08/07) ♡
- Crossing the milestone: landmark-based conditional survival after first-line CDK4/6 inhibitor therapy in HR+/HER2-metastatic breast cancer. (2026/08/07) ♡
- Stage-dependent performance and molecular subtype-specific relapse patterns on same-session [18F]FDG PET/contrast-enhanced CT in breast cancer. (2026/08/07) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Graded Exercise Therapy and Cognitive Behavioral Therapy for Fatigue in Patients With Breast Cancer: Protocol for a Randomized Controlled Pilot Study. (2026/08/07) ♡
- Mechanistic Insights into Secondary Lymphedema: The Role of Inflammatory Cytokines and Fibrotic Pathways in Post-Surgical Patients. (2026/08/07) ♡
- Long-term Outcomes of Slowly Proliferating Luminal A-like Invasive Lobular Carcinoma Versus Invasive Carcinoma of No Special Type. (2026/08/06) ♡
- Obstructed by Metastasis: Dual Biliary and Gastric Outlet Obstruction from Metastatic Breast Carcinoma. (2026/08/06) ♡
- Preoperative plasma anti-DNAJB8 autoantibody and postoperative outcomes in breast cancer: an exploratory analysis. (2026/08/06) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. P-VERIFY: Real-World Comparative Overall Survival and Progression-Free Survival of CDK4/6 Inhibitors Plus an Aromatase Inhibitor in Patients with HR+/HER2- Metastatic Breast Cancer in the USA-A Vodcast. (2026/08/06) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. CDK4/6 Inhibitors in Breast Cancer Therapy: Mechanisms, Resistance, and Emerging Opportunities. (2026/08/06) ♡
- Boosting Cancer Immunotherapy by Integrating Cuproptosis and Mild Photothermal Therapy in a Biomimetic Nanoplatform. (2026/08/06) ♡
- Electronic Patient-Reported Outcome Monitoring With Alert-Based Interventions in Metastatic Breast Cancer: A Randomized Clinical Trial. (2026/08/06) ♡
- Therapeutic Salmonella expressing apoptin and CEA elicits combined pro-apoptotic and immune-mediated anticancer effects. (2026/08/06) ♡
- Protein Corona Modulates Extracellular Vesicle Recognition at Glycan-Based Nanobiointerfaces. (2026/08/06) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Overcoming immune resistance through tumor microenvironment reprogramming: Emerging immunotherapeutic strategies and translational advances. (2026/08/06) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Imaging patterns and diagnostic challenges in metastatic invasive lobular carcinoma. (2026/08/06) ♡
- (68)Ga-HER2 PET/CT for Predicting Pathologic Response to Neoadjuvant Therapy at Early Treatment and Preoperative Stages in HER2-Positive Breast Cancer: A Prospective Study. (2026/08/06) ♡
- Social support and country-level factors associated with cancer screening participation in 18 European countries: a multilevel analysis of the European Health Interview Survey. (2026/08/06) ♡
- First-line treatment patterns and real-world survival outcomes in PD-L1-negative locally recurrent inoperable or metastatic triple-negative breast cancer in the United States. (2026/08/05) ♡
- Integrative Transcriptional and Chromatin Analyses Reveal Enhancer-Mediated Regulatory Programs Driving Breast Cancer Metastasis. (2026/08/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Migration of immune cells in tumors and inflammation: molecular mechanisms and therapeutic targets. (2026/08/05) ♡
- Radiomics Model Predicts Efficacy of First-Line CDK4/6 Inhibitor Combined with Endocrine Therapy in HR+/HER2- Advanced Breast Cancer. (2026/08/05) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. The tumour microenvironment influences long-term tamoxifen benefit in postmenopausal ER+/HER2- breast cancer patients: a secondary analysis of the randomised Stockholm Tamoxifen (STO-3) trial. (2026/08/05) ♡
- Consensus statements on the definition, diagnosis, and management of oligoprogressive disease: results of an expert survey of Kazakhstan Cancer Society. (2026/08/05) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Efficacy of Acupuncture for Insomnia After Chemotherapy in Breast Cancer: A Randomized Sham-Controlled Trial. (2026/08/05) ♡
- Clinical impact of (18)F-FES PET/CT-detected ER-positive conversion in metastatic breast cancer with ER-negative primary tumors. (2026/08/04) ♡
- Comparative Study of Myocutaneous Latissimus Dorsi Flap Breast Reconstruction With Implant Versus Lipofilling: Complication Rates and Risk Factors. (2026/08/04) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Brain metastases in triple-negative breast cancer: a systematic review of current trends, treatment strategies, and outcomes. (2026/08/04) ♡
- Functional CCR7A-mediated cellular responses are negatively modulated by the splice variant CCR7B. (2026/08/04) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Feasibility of a randomised controlled trial comparing opioid dose escalation with low-dose methadone addition for refractory cancer pain: JORTC-PAL23/NCCH2309 - protocol. (2026/08/04) ♡
- Improved risk prediction via cross-domain calibration in a retrospective case-control study. (2026/08/04) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Atypical orbital metastasis from invasive lobular breast carcinoma masquerading as a hordeolum. (2026/08/04) ♡
- Combining circulating tumor cells and tumor-derived extracellular vesicles for prognosis stratification in patients with metastatic breast cancer. (2026/08/04) ♡
- Moderating Role of Perceived Neighborhood Environment on Physical Activity and BMI Outcomes of a Diet and Physical Activity Intervention Among Latina Breast Cancer Survivors. (2026/08/04) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.